Kamińska D et al. |
Significant infections after hand transplantation in a Polish population. |
2014 |
Transplant. Proc. |
pmid:25380943
|
Tanabe K et al. |
Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750571
|
Claesson K et al. |
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. |
1998 |
Transplant. Proc. |
pmid:9636524
|
Morris-Stiff G et al. |
Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transplant. Proc. |
pmid:9636525
|
Montejo M et al. |
Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715869
|
Bruce DS et al. |
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532150
|
Peddi VR et al. |
Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9532151
|
Yamamoto S et al. |
FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808570
|
Pérez MJ et al. |
Cardiovascular risk factors after liver transplantation: analysis of related factors. |
2011 |
Transplant. Proc. |
pmid:21486587
|
Tanabe M et al. |
The influence of donor and recipient strains in isolated small bowel transplantation in rats. |
1994 |
Transplant. Proc. |
pmid:7527986
|
Tabasco-Minguillan J et al. |
Long-term insulin requirement after liver transplantation with FK 506 in American veterans. |
1993 |
Transplant. Proc. |
pmid:7679839
|
Manu M et al. |
Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience. |
2000 |
Transplant. Proc. |
pmid:11119912
|
Klintmalm GB et al. |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679840
|
Ericzon BG et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey. |
1990 |
Transplant. Proc. |
pmid:1689905
|
Kusne S et al. |
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1371626
|
Tanaka M et al. |
Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. |
1996 |
Transplant. Proc. |
pmid:8623341
|
Ye Q et al. |
Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. |
1996 |
Transplant. Proc. |
pmid:8623350
|
Pichard L et al. |
Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA. |
1991 |
Transplant. Proc. |
pmid:1721279
|
Faivre L et al. |
FK 506 dose in transplantation: from theory to practice. |
2001 |
Transplant. Proc. |
pmid:11406256
|
Ali MN et al. |
Case series: hemolytic uremic syndrome--another cause of transplant dysfunction. |
2013 |
Transplant. Proc. |
pmid:24182801
|
Gonzalez-Molina M et al. |
Mycophenolate mofetil and tacrolimus reduce mortality after deceased donor kidney transplantation. |
2012 |
Transplant. Proc. |
pmid:23146459
|
Lang M et al. |
Impact of immunosuppression in liver transplantation across a positive crossmatch. |
1998 |
Transplant. Proc. |
pmid:9636595
|
Batista F et al. |
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. |
2012 |
Transplant. Proc. |
pmid:23146461
|
Hu RH et al. |
Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression. |
2004 |
Transplant. Proc. |
pmid:15518757
|
Asano T et al. |
Increased tacrolimus trough levels in association with severe diarrhea, a case report. |
2004 |
Transplant. Proc. |
pmid:15518758
|
Hatori M et al. |
Clinicopathologic examination of no-episode biopsies in well-functioning renal allografts. |
1998 |
Transplant. Proc. |
pmid:9474971
|
Kawaoka T et al. |
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report. |
2015 |
Transplant. Proc. |
pmid:25891736
|
Moffatt SD and Metcalfe SM |
FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies. |
1999 |
Transplant. Proc. |
pmid:10578271
|
Sawai T et al. |
A successful induction of tolerance by perioperative intrathymic injection in rat "high-responder" heart transplantation. |
1999 |
Transplant. Proc. |
pmid:10578275
|
Andersson J et al. |
The effects of FK 506 on cytokine production are dependent on the mode of cell activation. |
1991 |
Transplant. Proc. |
pmid:1721311
|
Wang SC et al. |
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. |
1991 |
Transplant. Proc. |
pmid:1721312
|
Jacob DA et al. |
Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. |
2005 |
Transplant. Proc. |
pmid:15919432
|
Wasilewski G et al. |
Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? |
2014 |
Transplant. Proc. |
pmid:25380929
|
Ciancio G et al. |
Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center. |
|
Transplant. Proc. |
pmid:27569936
|
Chuang JP et al. |
Does immunosuppressive pharmacotherapy affect isoagglutinin titers? |
2008 |
Transplant. Proc. |
pmid:18929836
|
Chung YW et al. |
Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. |
2015 |
Transplant. Proc. |
pmid:25891728
|
Tannuri AC et al. |
Effects of immunosuppressants on hepatocyte cell mitosis during liver regeneration in growing animal models of partial hepatectomy. |
2008 |
Transplant. Proc. |
pmid:18589165
|
Bäckman L et al. |
Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity. |
1994 |
Transplant. Proc. |
pmid:7518160
|
Abu-Elmagd K et al. |
Management of intestinal transplantation in humans. |
1992 |
Transplant. Proc. |
pmid:1376523
|
Celli S et al. |
Mechanisms of protection from humoral rejection by a xenografted liver. |
1995 |
Transplant. Proc. |
pmid:7533395
|
Land W |
Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10616558
|
Tzakis AG et al. |
FK 506 versus cyclosporine in pediatric liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721343
|
Jain AK et al. |
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. |
2002 |
Transplant. Proc. |
pmid:12176474
|
Metcalfe SM et al. |
In vitro transcription and translation of the tumour suppressor protein P53: qualitative and quantitative effects of FK506 and rapamycin. |
1998 |
Transplant. Proc. |
pmid:9865315
|
Krämer BK et al. |
Cardiovascular risk estimates and risk factors in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919488
|
Wlodarczyk Z et al. |
Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy. |
2005 |
Transplant. Proc. |
pmid:15919489
|
Moro JA et al. |
Randomized prospective study of the evolution of renal function depending on the anticalcineurin used. |
2008 |
Transplant. Proc. |
pmid:19010143
|
Barrera-Pulido L et al. |
Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients. |
2008 |
Transplant. Proc. |
pmid:19010156
|
Nüssler NC et al. |
CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection. |
1996 |
Transplant. Proc. |
pmid:8907898
|
Scantlebury VP et al. |
Pediatric kidney transplantation at the University of Pittsburgh. |
1994 |
Transplant. Proc. |
pmid:7509095
|
Iaria G et al. |
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182769
|
Gojowy D et al. |
High Frequency of Arterial Hypertension in Patients After Liver Transplantation. |
2016 |
Transplant. Proc. |
pmid:27496479
|
Wilusz M et al. |
Effects of Immunosuppressive Drugs on Serum Fatty Acids of Phospholipids Fraction in Renal Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496457
|
Souza ER et al. |
Acute effects of FK 506 on glomerular hemodynamics. |
1992 |
Transplant. Proc. |
pmid:1281585
|
Pascual J et al. |
A low incidence of new-onset insulin-dependent diabetes mellitus using tacrolimus in kidney recipients in Europe. |
2003 |
Transplant. Proc. |
pmid:12962785
|
Morris SM et al. |
Disruption of renal function and gene expression by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721375
|
Rashid I et al. |
Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176520
|
Lagodziński Z et al. |
Effect of FK 506 on B-cell responses. |
1991 |
Transplant. Proc. |
pmid:1703359
|
Fukushima N et al. |
Prolonged survival of pig cardiac xenografts in baboons by sequential cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9838671
|
Schulz T et al. |
Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083251
|
Sharma A et al. |
Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790252
|
Burke GW et al. |
Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123275
|
Becker G et al. |
Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8962228
|
Büttemeyer R et al. |
Peripheral nerve allotransplant immunosuppressed with FK 506: preliminary results. |
1995 |
Transplant. Proc. |
pmid:7536979
|
Muirhead N et al. |
A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years. |
2003 |
Transplant. Proc. |
pmid:14611965
|
Lee H et al. |
Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience. |
2018 |
Transplant. Proc. |
pmid:29880348
|
Lopez OL et al. |
Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721400
|
Takaya S et al. |
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. |
1993 |
Transplant. Proc. |
pmid:7685953
|
Boucher A et al. |
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176582
|
Fellermann K et al. |
Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease. |
2001 |
Transplant. Proc. |
pmid:11377517
|
Suwelack B et al. |
Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels. |
2002 |
Transplant. Proc. |
pmid:12176585
|
Salizzoni M et al. |
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377521
|
El Haggan W et al. |
One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176589
|
Jiang H et al. |
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266931
|
Orsenigo R et al. |
FK506 and SMS 201-995: effect on heterotopic heart transplantation in rats. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266956
|
Cirocco RE et al. |
Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083604
|
Levy GA |
Neoral is superior to FK 506 in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723293
|
Mendes J et al. |
Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19376366
|
McMaster P et al. |
Liver transplantation: changing goals in immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9723295
|
Beckebaum S et al. |
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. |
2004 |
Transplant. Proc. |
pmid:15621120
|
Rintala JM et al. |
The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. |
2006 |
Transplant. Proc. |
pmid:17175234
|
Ishikawa S et al. |
Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report. |
2018 |
Transplant. Proc. |
pmid:29661455
|
Valdivia LA et al. |
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721432
|
Kawano K et al. |
FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation. |
1996 |
Transplant. Proc. |
pmid:8658938
|
Zajicek A et al. |
Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176653
|
Murase N et al. |
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. |
1987 |
Transplant. Proc. |
pmid:2445081
|
Peltekian K et al. |
De novo use of low-dose tacrolimus and sirolimus in liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267318
|
Gómez G et al. |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin. |
1999 |
Transplant. Proc. |
pmid:10500563
|
Khoury N et al. |
Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11134791
|
Velioglu A et al. |
Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. |
2015 |
Transplant. Proc. |
pmid:26093733
|
Ito Y et al. |
Complete replacement of tracheal epithelia by the host promotes spontaneous acceptance of orthotopic tracheal allografts in rats. |
2004 |
Transplant. Proc. |
pmid:15561264
|
Kiji T et al. |
Relationship between immunological rejection and matrix GLA protein in cryopreserved vascular allografts. |
2004 |
Transplant. Proc. |
pmid:15561265
|
Nossal GJ |
Summary of the First International FK 506 Congress: perspectives and prospects. |
1991 |
Transplant. Proc. |
pmid:1721464
|
Bahra M et al. |
Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage. |
2002 |
Transplant. Proc. |
pmid:12431663
|
Miura S et al. |
Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion. |
1998 |
Transplant. Proc. |
pmid:9636492
|
Wojciechowski D et al. |
Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923623
|
Nanmoku K et al. |
Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923615
|
Girman P et al. |
Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692391
|
Montero EF et al. |
Gangliosides on intestinal microcirculation and animal survival during reperfusion. |
2004 |
Transplant. Proc. |
pmid:15194293
|
Flavin T et al. |
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts. |
1991 |
Transplant. Proc. |
pmid:1703701
|